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Background:
•

Novel immune biomarkers are constantly discovered, sometimes
replacing old markers for identification.

•

Antibodies – including those targeting immune markers – should be
rigorously validated via methods such as immunohistochemistry
(IHC) to ensure specificity.

•

Single-tissue IHC staining and analysis is resource and timeconsuming.

•

Tissue Microarrays (TMAs) are an efficient platform to implement
validation using multiple tissues, which allows technical replicates
and on-slide controls.1,2

Methods-cont.:

Methods-cont.:
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Fig 6. Image of Anti-MBP stained WT eye tissue (specific). RET –
retina. ON – optic nerve.
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Fig 3. (Steps 4 -5). (4) Caliper used to measure donor block offset. Offsets of the donor blocks relative to the TMA recipient block were measured
prior to tissue core extraction. (5) TMA generation using the Galileo semiautomatic tissue microarrayer. Cylindrical tissue cores were extracted
from single-organ blocks (donor blocks) and inserted into the recipient TMA block.
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Fig 1. Sample Multiplex Stain of brain tumor border. Rigorous
antibody validation has significant implications for many procedures,
such as mIHC.

Methods:
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Fig 5. (Step 6). Image of H&E stained TMA section.
5 μm sections underwent IHC staining with respective
antibodies.

Fig 6. (Step 7). Image of Vectra
Polaris. Slides are scanned on
H&E, Brightfield preset.

Fig 7. (Step 8). Sample portion of GeneCards
protein expression profile of CSF1R. IHCstained sections are analyzed using existing
literature, as well as protein and gene expression
databases. Adapted from GeneCards.

Fig 7. Panel of Anti-LAG3 stained tissues (nonspecific). WT Spleen
at 20x – specific (Top). NSG spleen at 20x - nonspecific (Bottom).

Results:

(https://www.genecards.org/cgi-bin/carddisp.pl?gene=CSF1R).

We classified anti-CD20 as moderately specific because while the NSG
spleen showed positive signal, the NSG kidney showed no signal as
expected despite the positive signal in the WT kidney. We classified
anti-CSF1R as moderately specific because the WT spleen showed
positive signal, as expected, but the NSG spleen showed considerable
background staining. We classified anti-LAG3 as nonspecific because
the WT spleen shows positive signal, but the NSG spleen showed more
positive signal in comparison to the WT spleen. Similarly, we classified
anti-NCR1 as nonspecific because the WT spleen shows positive
signal, but the NSG spleen showed more positive signal in comparison
to the WT spleen. Lastly, we classified anti-FOXP3 as nonspecific
because both the WT and NSG spleen show similar staining intensity.
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Conclusions:
•

TMAs mediate rapid validation of antibodies against immune markers,
eliminating the need for single-tissue IHC staining and analysis.

•

mIHC paired with TMA utilization could further increase the efficiency
of validating antibodies.
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Fig 2. (Step 1-3). (1) Image of C57BL/6J (wild-type) mouse. Organs were
harvested from 3 wild-type (WT) and 3 NSG mice. (2) Paraffin-embedded
WT mouse liver. Paraffin-embedded single-organ blocks were sectioned.
(3) Sample QuPath annotation of WT mouse brain. H&E-stained 5μm
slices are scanned and resulting scans are annotated with QuPath.

Fig 6. Map of TMA design with 60-1mm cores.
Tissues from WT mice and NSG mice are labeled
blue and white, respectively. Spln – spleen. Liv –
liver. Lng – lung. Panc – pancreas. Thy - thymus.
LN – lmph node. Ret – retina. Brn – brain. Kid –
kidney. Hrt – heart.

•

Fig 7. Panel of Anti-CD20 stained tissues (moderately specific). WT Spleen scanned at 20x (Top
left). NSG spleen scanned at 20x (Top right). WT kidney scanned at 20x (Bottom left). WT Brain
scanned at 20x (Bottom right).
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